Wednesday, July 8, 2026

Patent directory · USPTO A61K / A61P

Patents matching “The United States of America, As Represented By”

2,152 pharma patents match "The United States of America, As Represented By" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 2,152
Index total 30,257
Page 61 / 90

Quick answer

This filtered view shows 2,152 pharmaceutical patents matching "The United States of America, As Represented By" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

2,152 results for “The United States of America, As Represented By” · 30,257 patents in full index Clear search

  1. US 7892786

    Methods for expression and purification of immunotoxins

    The United States of America, as represented by the Department of Health and Human Services · Granted Feb 22, 2011 · Expires Feb 17, 2031

    granted
  2. US 7892738

    Pot1 alternative splicing variants

    The United States of America, as represented by the Department of Health and Human Services · Granted Feb 22, 2011 · Expires Feb 17, 2031

    granted
  3. US 7888116

    Uses of notch receptors, notch ligands, and notch modulators in methods related to metabolic diseases

    The United States of America, as represented by the Department of Health and Human Services · Granted Feb 15, 2011 · Expires Feb 10, 2031

    granted
  4. US 7887818

    Neospora caninum vaccine

    The United States of America, as represented by the Secretary of Agriculture · Granted Feb 15, 2011 · Expires Feb 10, 2031

    granted
  5. US 7887812

    Live attenuated Leishmania vaccines

    The United States of America, as represented by the Department of Health and Human Services · Granted Feb 15, 2011 · Expires Feb 10, 2031

    granted
  6. US 7883710

    Peptide vaccines against Group A streptococci

    The United States of America, as represented by the Department of Health and Human Services · Granted Feb 8, 2011 · Expires Feb 3, 2031

    granted
  7. US 7884178

    Griffithsin, glycosylation-resistant griffithsin, and related conjugates, compositions, nucleic acids, vectors, host cells, methods of production and methods of use

    The United States of America, as represented by the Department of Health and Human Services · Granted Feb 8, 2011 · Expires Feb 3, 2031

    granted
  8. US 7879810

    Immunostimulatory nucleic acid molecules

    The United States of America, as represented by the Department of Health and Human Services · Granted Feb 1, 2011 · Expires Jan 27, 2031

    granted
  9. US 7875450

    Virus-like particles for the induction of autoantibodies

    The United States of America, as represented by the Department of Health and Human Services · Granted Jan 25, 2011 · Expires Jan 20, 2031

    granted
  10. US 7875262

    Aqueous starch-oil dispersions having improved UV stability and absorbing ability

    The United States of America, as represented by the Secretary of Agriculture · Granted Jan 25, 2011 · Expires Jan 20, 2031

    granted
  11. US 7871981

    Inhibition of cell motility, angiogenesis, and metastasis

    The United States of America, as represented by the Department of Health and Human Services · Granted Jan 18, 2011 · Expires Jan 13, 2031

    granted
  12. US 7871986

    Methods of stimulating an immune response against prostate specific antigen

    The United States of America, as represented by the Department of Health and Human Services · Granted Jan 18, 2011 · Expires Jan 13, 2031

    granted
  13. US 7867977

    Immunogenic peptides and methods of use for treating and preventing cancer

    The United States of America, as represented by the Department of Health and Human Services · Granted Jan 11, 2011 · Expires Jan 6, 2031

    granted
  14. US 7867500

    Cofactor that modulates steroid receptor activities

    The United States of America, as represented by the Department of Health and Human Services · Granted Jan 11, 2011 · Expires Jan 6, 2031

    granted
  15. US 7867974

    Induction of tolerance by oral administration of factor VIII and treatment of hemophilia

    The United States of America, as represented by the Department of Health and Human Services · Granted Jan 11, 2011 · Expires Jan 6, 2031

    granted
  16. US 7863262

    Nitroxyl progenitors in the treatment of heart failure

    The United States of America, as represented by the Department of Health and Human Services · Granted Jan 4, 2011 · Expires Dec 30, 2030

    granted
  17. US 7862815

    Methods for inhibiting angiogenesis with inhibitors of proadrenomedullin N-terminal 20 peptide (PAMP)

    The United States of America, as represented by the Department of Health and Human Services · Granted Jan 4, 2011 · Expires Dec 30, 2030

    granted
  18. US 7855076

    Use of discoidin domain receptor 1 (DDR1) and agents that affect the DDR1/collagen pathway

    The United States of America, as represented by the Department of Health and Human Services · Granted Dec 21, 2010 · Expires Dec 16, 2030

    granted
  19. US 7855276

    Framework residue substituted humanized COL-1 antibodies and their use

    The United States of America, as represented by the Department of Health and Human Services · Granted Dec 21, 2010 · Expires Dec 16, 2030

    granted
  20. US 7851194

    West Nile viruses with mutations in the 3′ terminal stem and loop secondary structure for use as live virus vaccines

    The United States of America, as represented by the Department of Health and Human Services · Granted Dec 14, 2010 · Expires Dec 9, 2030

    granted
  21. US 7846455

    Attenuated chimeric respiratory syncytial virus

    The United States of America, as represented by the Department of Health and Human Services · Granted Dec 7, 2010 · Expires Dec 2, 2030

    granted
  22. US 7846454

    Cloned genomes of infectious hepatitis C viruses and uses thereof

    The United States of America, as represented by the Department of Health and Human Services · Granted Dec 7, 2010 · Expires Dec 2, 2030

    granted
  23. US 7842729

    Anti tubercular drug: compositions and methods

    The United States of America, as represented by the Department of Health and Human Services · Granted Nov 30, 2010 · Expires Nov 25, 2030

    granted
  24. US 7842798

    Production of attenuated, human-bovine chimeric respiratory syncytial virus vaccines

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Nov 30, 2010 · Expires Nov 25, 2030

    granted